Dr Joan O’Brien, chair of the University of Pennsylvania’s Department of Ophthalmology, Scheie Eye Institute, Philadelphia, and primary investigator of POAAGG, joins our panel of experts on April 10th to discuss bias in genetic studies and what is being done to remove it.
Efficiently translating genomic research into the clinic is one of the most important steps in the development of the field. The clinic is where we will see things come to fruition.
Access to electronic patient data has huge potential, and with the federal Centers for Medicare and Medicaid Services calling for entry, we could soon be seeing the impact in the healthcare system.
Our panel of experts come together to discuss the benefits and drawbacks on the use of saliva DNA in genetic studies and how it’s currently being used to diminish biases in our databases and uncovering the role of epigenetics in psychiatric disorders.
Introducing our new webinar series, The Genome Spot. Each month we’ll be picking the brains of some of the leading researchers, to uncover some of the key movements, challenges and solutions in the field.
Last week, a 13-year-old boy found himself at the centre of medical history in the US as he became the first to receive an FDA-approved gene therapy for an inherited form of blindness.
Cofactor Genomics, the developer of advanced RNA analysis tools, has announced that it has entered into an agreement with the National Cancer Institute, to demonstrate the clinical utility of its immune-profiling assay, Cofactor Paragon.
A new promising drug that could prove an effective treatment for breast cancer patients who have proved unresponsive to hormone therapy, has entered human trials.
Color’s new DNA test identifies inherited heart conditions, where the idea is for customers to work with their doctor to come up with a plan to detect conditions early and prevent medical problems.
Artificial Intelligence has been going from strength to strength in recent weeks, but its potential doesn’t mean that the diagnostic is ready for the clinic.